Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders

Size: px
Start display at page:

Download "Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders"

Transcription

1 Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders March 20, 2013 Pamela Petersen- Baston, MPA, CAP, CPP I r v i n e B l v d., S u i t e I r v i n e, C A n c s a c c f f u t u r e s. o r g w w w. n c s a c w. s a m h s a. g o v

2 A Program of the Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment and the Administration on Children, Youth and Families Children s Bureau Office on Child Abuse and Neglect 2

3 NCSACW Mission Developing knowledge and providing technical assistance to federal, state, local agencies and tribes to improve outcomes for families with substance use disorders in the child welfare and family court systems

4 I r v i n e B l v d., S u i t e I r v i n e, C A n c s a c c f f u t u r e s. o r g w w w. n c s a c w. s a m h s a. g o v Important Definitions

5 Important definitions Nonmedical use: Use of prescription drugs without a prescription, or use that occurred simply for the experience or feeling the effects caused by the drug rather than for legitimate medical reasons (over-the-counter use and legitimate use of prescription pain relievers are not included). 1

6 Important definitions Medication-Assisted Treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide a wholepatient approach to the treatment of substance use disorders 2 with an ultimate goal of patient recovery with full social function. 3 MMT: Methadone Maintenance Treatment - Dispensing methadone at stable dosage levels for a period in excess of 21 days in the supervised treatment of an individual for opioid addiction. 4

7 Goals of MAT MAT is prescribed to address very specific and highly individualized goals that vary by person: Prevention or reduction of withdrawal symptoms Prevention or reduction of drug craving Prevention of relapse to use of addictive drug Restoration to or toward normalcy of any physiological function disrupted by drug abuse Blockade of euphoric effects of illicit selfadministered

8 MAT is not a new practice MAT is not new! While you may be hearing more about the use of medications (in combination with behavioral therapies) to address the emerging prescription painkiller epidemic, MAT has been in place as a proven effective practice for decades e.g. Disulfiram (Antabuse ) for more than 50 years and methadone for more than 40 years. 5

9 Treatment of alcohol dependence In the US, MAT has been demonstrated to be effective in the treatment of alcohol dependence with Food and Drug Administration (FDA) approved drugs such as: Disulfiram (Antabuse ) Naltrexone (oral = ReVia, Depade or monthly extended-release injectable Vivitrol ) Acamprosate (Campral ) 6

10 Other medications for alcohol In addition, some benzodiazepines (Valium and Xanex) have been approved to treat alcohol withdrawal symptoms. 7 Other drugs are not FDA-approved to treat alcohol abuse, but have, in a research setting, shown promise in reducing drinking. 8

11 Medical marijuana Marijuana has been used to treat Loss of vision from glaucoma Nausea that can come with AIDS and cancer treatments The pain of multiple sclerosis Marinol is a prescription medicine that contains marijuana s active ingredient. Marinol is used to treat nausea and vomiting. 9 Note: There is no reason to believe that inhaled smoke is an acceptable delivery mode. 10

12 MI s nonmedical use of pain relievers Michigan rates among the top 15 at 5.11% nationally for nonmedical use (e.g. misuse) of pain relievers among persons 12 and older ( NSDUH data) and also among year olds 11.74%. During this same time period, Michigan s rate among year olds was 6.35%. 11

13 Common Opioids12, 13 Heroin (injected, smoked, or nasally inhaled) Buprenorphine (e.g., Suboxone, Subutex) Fentanyl (Duragesic patch, lozenge, solution) Hydromorphone (Dilaudid) Hydrocodone (e.g., Vicodin, Lortab, Lorcet) Methadone (Dolophine or Methadose in diskette/wafer, pills, liquid) Morphine (MSContin, MSIR, Avinza, or Kadian) Oxycodone (e.g., OxyContin, Percodan, Percocet) Codeine an ingredient in some cough syrups and in one Tylenol product

14 Treatment of opioid dependence 14 In the US, MAT has been demonstrated to be effective in the treatment of opioid dependence with: Methadone (Dolophine or Methadose) Buprenorphine (Subutex, Suboxone) Naltrexone (oral = ReVia, Depade or monthly extended-release injectable Vivitrol )

15 Methods of Dispensing Methadone to treat addiction is dispensed only at specially licensed treatment centers. Buprenorphine and naltrexone are dispensed at treatment centers or prescribed by doctors. 15 A doctor must have special approval to prescribe buprenorphine. Some people go to the treatment center or doctor s office every time they need to take their medication. People who are stable in recovery may be prescribed a supply of medication to take at home. 16

16 Methadone Methadone is a synthetic opioid that blocks the effects of heroin and other prescription drugs containing opiates. Used successfully for more than 40 years, methadone has been shown to eliminate withdrawal symptoms and relieve drug cravings from heroin and prescription opiate medications. 17 Methadone has been in use since the 1960s to treat heroin addiction and is still an excellent treatment option today. 18

17 Methadone Methadone is an agonist that mitigates opioid withdrawal symptoms and, at higher doses, blocks the effects of heroin and other drugs containing opiates. Methadone compliance reduces injection opioid use, thereby helping to close off one route of HIV transmission for patients. 19

18 Methadone Methadone must be dispensed to patients at a Substance Abuse and Mental Health Services Administration (SAMHSA)-certified opioid treatment program (OTP) facility with daily doses provided at the clinic until the patient is deemed stable enough to receive take-home doses. 20

19 Methadone treatment Methadone is taken daily (liquid and a wafer form). It has been used successfully for more than 40 years in the treatment of opioid dependence. Medication is integrated with psychosocial therapy to address the unique needs of each patient.

20 Buprenorphine for opioid dependence Buprenorphine (Suboxone and Subutex ) relieves drug cravings without producing the high or dangerous side effects of other opioids. The FDA approved buprenorphine in 2002, is available at OTPs, but is most often prescribed by physicians in office-based settings making it more accessible than methadone. Physicians have to first receive special training, be granted a DEA waiver and can only treat up to 100 patients at a time.

21 How different from methadone? Only qualified doctors with the necessary DEA (Drug Enforcement Agency) identification number are able to start in-office buprenorphine treatment and provide prescriptions for ongoing medication. CSAT (Center for Substance Abuse Treatment) will maintain a database to help patients locate qualified doctors. These medications are available in most commercial pharmacies. 21

22 Naltrexone for opioid dependence Naltrexone is a non-addictive antagonist that prevents opioid receptors from being activated by agonist compounds, such as heroin or prescription pain killers, and is reported to reduce craving and prevent relapse. 22 If a patient who has been administered naltrexone attempts to continue taking opioids, he or she is unable to feel any of the opioid s effects due to naltrexone s blocking action. 23

23 Naltrexone for opioid dependence Naltrexone can be prescribed by any healthcare provider who is licensed to prescribe medications (e.g., physician, doctor of osteopathic medicine, physician assistant, and nurse practitioner). Special training is not required; the medication can be administered in OTP clinics. 24

24 MAT for opioid has 3 elements Medication-assisted treatment is one way to help those with opioid addiction recover their lives. There are three, equally important parts to this form of treatment: Medication Counseling Support from family and friends. 25 As we will discuss later, system support is also essential as is reducing MAT barriers and stigma.

25 Duration of treatment medication People can safely take treatment medication as long as needed for months, a year, several years, even for life. Plans to stop taking a medication should ALWAYS be discussed with a doctor. 26

26 Benefits of MAT 27 As part of a comprehensive treatment program, MAT has been shown to: Improve survival Increase retention in treatment Decrease illicit opiate use Decrease hepatitis and HIV seroconversion Decrease criminal activities Increase employment Improve birth outcomes among opioid dependent pregnant women

27 I r v i n e B l v d., S u i t e I r v i n e, C A n c s a c c f f u t u r e s. o r g w w w. n c s a c w. s a m h s a. g o v Pregnancy and MAT

28 Treating opioid dependency during pregnancy 28 Methadone has been accepted since the late 1970s to treat opioid addiction during pregnancy. In 1998, an NIH consensus panel recommended methadone maintenance as standard of care for pregnant women with opioid addiction. The FDA licensed and regulated methadone treatment programs, including treatment for pregnant women starting in 2001.

29 ASAM/ACOG Committee Opinion The current state of care for pregnant women with opioid dependence is referral for opioidassisted therapy with methadone, but emerging evidence suggests that buprenorphine also should be considered. Medically supervised tapered doses of opioids during pregnancy often result in relapse to former use. Abrupt discontinuation of opioids in an opioiddependent pregnant woman can result in preterm labor, fetal distress, or fetal demise. 29

30 Methadone and Pregnancy 30 Withdrawal for pregnant women is especially dangerous because it causes the uterus to contract and may bring on miscarriage or premature birth. By blocking withdrawal symptoms, MMT can save the baby s life. Additionally, MMT can help the mother stop using needles, which is a primary route of infection for drug users. More importantly, it can allow the mother to regain quality of life.

31 Methadone and pregnancy 31 Undergoing MMT while pregnant will not cause birth defects for the baby, but some infants may go through withdrawal after birth. Withdrawal does not mean the baby is addicted. Studies have shown that the dose of medication has no bearing on whether or not the baby experiences withdrawal. Infant withdrawal usually begins a few days after the baby is born but may begin two to four weeks after birth.

32 Buprenorphine and pregnancy 32 Current guidelines recommend that buprenorphine be prescribed to pregnant women only when the benefits outweigh the risks and the patent has refused methadone (CSAT, 2004)

33 I r v i n e B l v d., S u i t e I r v i n e, C A n c s a c c f f u t u r e s. o r g w w w. n c s a c w. s a m h s a. g o v Child Welfare Issues

34 Issues for Child Welfare Systems What are the issues? Use of MAT as exclusionary criteria for child welfare programs, particularly Family Drug Courts. Misunderstanding of the use of MAT, particularly Methadone treatment, in substance abuse treatment and how it relates to child safety. Requirement of minimal dosing of MAT medications for pregnant women or as a term for reunification. Positive toxicology result for methadone at birth as a presumptive cause for child removal. TEXT PAGE

35 MAT Misunderstood Not all court officials, child welfare staff, or even behavioral health professionals understand that MMT is the recommended course of treatment for pregnant opioid-dependent women and that it reflects a mother s commitment to living a sober and responsible life.

36 Medically assisted detoxification For opioid abusers who do not wish to enter treatment or do not qualify for ongoing maintenance therapy, some treatment programs provide medically assisted detoxification services, which involve weaning patients off addictive substances and managing withdrawal. However, research shows such programs are closely associated with relapse. 33

37 Medically assisted detoxification Medically assisted detoxification is only the first stage of addiction treatment and by itself does little to change long-term drug abuse. Although medically assisted detoxification can safely manage the acute physical symptoms of withdrawal and can, for some, pave the way for effective long-term addiction treatment, detoxification alone is rarely sufficient to help addicted individuals achieve long-term abstinence. 34

38 Medically assisted detoxification Patients should be encouraged to continue drug treatment following detoxification. Motivational enhancement and incentive strategies, begun at initial patient intake, can improve treatment engagement. 35 Because tolerance to opioids fades rapidly even during a short period of abstinence, one episode of opioid misuse following detoxification can result in a life-threatening or deadly overdose. 36

39 MAT myth busters Methadone clients are still using (continuing drug use) and not really engaged in recovery. Clients get high on methadone and Suboxone. FACT: Taking medication for opioid addiction is like taking medication to control heart disease or diabetes. It is NOT the same as substituting one addictive drug for another. Used properly, the medication does NOT create a new addiction. It helps people manage their addiction so that the benefits of recovery can be maintained. 37 With correct dosing, MAT clients withdrawal symptoms are ameliorated and no high is produced.

40 MAT myth busters 38 Some child welfare system-involved pregnant women participating in MAT are being told by some child welfare staff to get off of the MAT as they are harming their baby. Others are asked about their plans to decrease their doses and discontinue MAT. FACT: Methadone is not harmful to the fetus if the mother is stable and under the medical care of an OTP. No one should practice medicine without a license! Moreover, this advice is contraindicated and could result in far more harm to both mother, fetus and baby.

41 MAT myth busters Often recommended to reduce maternal methadone dose to avoid harming fetus. FACT: A non-therapeutic maternal dose may promote supplemental drug use and increase risk to the fetus. 39 Bottom line MAT involves extremely complex, highly individualized medical treatments that should only be considered after consultation with a physician who has received training in these therapies.

42 MAT myth busters 40 Positive toxicology result for methadone at birth as a presumptive cause for child removal. FACT: Methadone (or other properly administered medication) in a stabilized patient will not cause sedation or prevent the individual from being a responsible parent. Methadone maintenance treatment and buprenorphine do not have the narcotizing effects of heroin and does not trade one addiction for another.

43 MAT myth busters 41 Use of MAT as exclusionary criteria for child welfare programs, particularly Family Drug Courts. Some parents are required by child welfare and/or court systems to discontinue MAT as a pre-requisite to reunification. FACT: If parents are pushed to abandon their MAT protocol destabilization of a family could result.

44 Myth busters 42 It is not safe for mothers receiving MAT to breast-feed their baby. FACT: Breast-feeding is safe unless the mother has an infectious disease, such as HIV. Hepatitis C-positive women are able to safely breastfeed but should check with their physicians first. CPS representatives should work with OTPs and read the SAMHSA/CSAT publication TIP #43, Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs, especially Chapter 13- Treating Pregnancy.

45 Considerations for Child Welfare Policy and Practice I r v i n e B l v d., S u i t e I r v i n e, C A n c s a c c f f u t u r e s. o r g w w w. n c s a c w. s a m h s a. g o v

46 MAT Policy and Practice Considerations Discussion & jurisdiction examples of: Collaboration with multiple stakeholders primary care providers, substance abuse treatment/ MAT providers and the courts Cross systems release of information Cross systems role clarification Clearly written policies and guidelines for clients/parents Clearly written policies and guidelines for staff

47 Policy and Practice Framework: Five Points of Intervention (Apply to SEI) 1. Pre-pregnancy awareness of substance use effects 2. Prenatal screening and assessment Initiate enhanced prenatal services Child 3. Identification at Birth Parent 4. Ensure infant s safety and respond to infant s needs System Linkages Respond to parents needs 5. Identify and respond to the needs of Infant Preschooler Child Adolescent System Linkages Identify and respond to parents needs

48 SEI - The Framework: Five Points of Intervention Pre-pregnancy and public awareness Prenatal screening and support Screening at birth Services to infants 0-3 and beyond Services to parents So the birth event is one of several opportunities to make a difference, not the only one!

49 Closing: Making the business case for MAT I r v i n e B l v d., S u i t e I r v i n e, C A n c s a c c f f u t u r e s. o r g w w w. n c s a c w. s a m h s a. g o v

50 SAMHSA MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders. Research shows that when treating substance-use disorders, a combination of medication and behavioral therapies is most successful. Medication assisted treatment (MAT) is clinically driven with a focus on individualized patient care. 43

51 White House/ONDCP Insurers and policy makers must strive to learn about available medicines and promote policies that ensure that use of these medications is covered as part of a comprehensive approach to treating prescription and illicit drug dependence. 44

52 NIDA The National Institute of Drug Abuse (NIDA) Principles of Effective Treatment states the following: Medications are an important element of treatment for many patients, especially when combined with counseling and other behavioral therapies. For example, methadone, buprenorphine, and naltrexone (including a new long-acting formulation) are effective in helping individuals addicted to heroin or other opioids stabilize their lives and reduce their illicit drug use. 45

53 NIDA cont. Acamprosate, disulfiram, and naltrexone are medications approved for treating alcohol dependence. For persons addicted to nicotine, a nicotine replacement product (available as patches, gum, lozenges, or nasal spray) or an oral medication (such as bupropion or varenicline) can be an effective component of treatment when part of a comprehensive behavioral treatment program. 46

54 The National Quality Forum The National Quality Forum has developed consensus standards for addressing substance use illnesses. Four of the eleven standards focus on the use of medications. Specifically, they state that everyone receiving detoxification or treatment for opiate, alcohol, or nicotine dependency should be offered medications. 47

55 Summary Medications may also become an essential component of an ongoing treatment plan, enabling opioid-addicted persons to regain control of their health and their lives. 48

56 I r v i n e B l v d., S u i t e I r v i n e, C A n c s a c c f f u t u r e s. o r g w w w. n c s a c w. s a m h s a. g o v Resources

57 10 Element Framework Training and Staff Development Understanding Substance Abuse and Facilitating Recovery: A Guide for Child Welfare Workers Discusses the relationship of alcohol and drugs to families in the child welfare system Provides information on the biological, psychological, and social processes of alcohol and drug addiction to help staff recognize when substance abuse is a risk factor in their cases Describes strategies to facilitate and support alcohol and drug treatment and recovery for families affected by substance use disorders Available online at TEXT PAGE

58 Web-based Screening Tool NIDA provides a Web-based tool that helps clinicians screen for tobacco, alcohol, and illicit and nonmedical prescription drug use, and suggests levels of intervention.

59 pdfs/tip43_curriculum.pdf

60 Buprenorphine For more information about contact the Center for Substance Abuse Treatment (CSAT) Buprenorphine Information Center at 866-BUP- CSAT, or via at or

61 To Obtain a Copy: /improving/daily-practice-client.aspx

62 Contact Information Pamela Petersen-Baston, MPA, CAP, CPP National Center on Substance Abuse And Child Welfare, Children and Family Futures Phone: 1 (866)

63 Questions and Discussion

Opioid/Opiate Dependent Pregnant Women

Opioid/Opiate Dependent Pregnant Women Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than

More information

Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction

Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently

More information

Medication Assisted Therapy and Pregnancy: An Introduction

Medication Assisted Therapy and Pregnancy: An Introduction Medication Assisted Therapy and Pregnancy: An Introduction Deborah A. Orr, Ph.D. The Center For Drug Free Living Adapted from the NIDA Blending Initiative Curriculum Presentation Objectives Define opioids

More information

Methadone. Buprenorphine 10/9/2015

Methadone. Buprenorphine 10/9/2015 Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious

More information

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,

More information

The ABCs of Medication Assisted Treatment

The ABCs of Medication Assisted Treatment The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment

More information

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This

More information

The Need for Medication-Assisted Treatment (MAT)

The Need for Medication-Assisted Treatment (MAT) Presenters Erin Hall MSOT Hon. Kyle B. Haskins Closed Doors or Welcome Mat? Opening the Way for Medication-Assisted Treatment in Family Drug Courts Oklahoma Specialty Court Conference Thursday September

More information

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,

More information

Medication Assisted Treatment

Medication Assisted Treatment Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice

More information

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,

More information

Joel Millard, DSW, LCSW Dave Felt, LCSW

Joel Millard, DSW, LCSW Dave Felt, LCSW Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used

More information

Medication Assisted Treatment of Substance Use Disorders

Medication Assisted Treatment of Substance Use Disorders Medication Assisted Treatment of Substance Use Disorders April 8, 2015 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary Care

More information

DrugFacts: Treatment Approaches for Drug Addiction

DrugFacts: Treatment Approaches for Drug Addiction DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the

More information

John R. Kasich, Governor Orman Hall, Director

John R. Kasich, Governor Orman Hall, Director John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic

More information

Practice Protocol. Buprenorphine Guidance Protocol

Practice Protocol. Buprenorphine Guidance Protocol Practice Protocol Buprenorphine Guidance Protocol Developed by the Arizona Department of Health Services Division of Behavioral Health Services Effective Date: 02/23/11 Title Buprenorphine Guidance Protocol

More information

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Introduction March 3, 2008 By: Suzanne Gelber, MSW, Ph.D., Managing Partner, The Avisa Group Defining Characteristics

More information

Medication is not a part of treatment.

Medication is not a part of treatment. Medication is not a part of treatment. Medication can be an effective part of treatment. Medication is used in the treatment of many diseases, including addiction. Medical decisions must be made by trained

More information

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported

More information

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by

More information

Medication-Assisted Treatment for Opioid Addiction

Medication-Assisted Treatment for Opioid Addiction Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid

More information

Opioid overdose can occur when a patient misunderstands the directions

Opioid overdose can occur when a patient misunderstands the directions Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription

More information

Medication-Assisted Addiction Treatment

Medication-Assisted Addiction Treatment Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling

More information

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal

More information

Ohio Legislative Service Commission

Ohio Legislative Service Commission Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing

More information

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

Beyond SBIRT: Integrating Addiction Medicine into Primary Care Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison

More information

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California 2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 9:30am - 10:30am Opioid Addiction and Buprenorphine Use * Presented by

More information

Frequently asked questions

Frequently asked questions Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs

More information

8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview

8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview Who We Are BHG s Medical Mission BHG Company Overview Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. Our treatment centers provide pharmacotherapeutic maintenance

More information

Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation

Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration

More information

Medication-Assisted Treatment for Opioid Addiction

Medication-Assisted Treatment for Opioid Addiction Medication-Assisted Treatment for Opioid Addiction Facts for Families and Friends U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance

More information

Use of Pharmacotherapies by Substance Abuse Treatment Facilities

Use of Pharmacotherapies by Substance Abuse Treatment Facilities Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1

More information

Policy Consideration and Collaborative Partnerships: Working with Opioid Dependent Pregnant and Parenting Women

Policy Consideration and Collaborative Partnerships: Working with Opioid Dependent Pregnant and Parenting Women Policy Consideration and Collaborative Partnerships: Working with Opioid Dependent Pregnant and Parenting Women 2015 San Diego International Conference on Child and Family Maltreatment January 26-30, 2015

More information

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health TESTIMONY of the American Medical Association before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health Re: Examining Legislative Proposals to Combat our Nation's

More information

Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.

Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule

More information

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,

More information

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal

More information

Welcome. How Do I Ask Questions? Agenda. Thank you for joining us today. The webinar will begin in a few moments.

Welcome. How Do I Ask Questions? Agenda. Thank you for joining us today. The webinar will begin in a few moments. Welcome How Do I Ask Questions? Thank you for joining us today. The webinar will begin in a few moments. If you are experiencing technical problems with the GoToWebinar program, contact the GoToWebinar

More information

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction

More information

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH. Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF

More information

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive. Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.

More information

Opioid Treatment Services, Office-Based Opioid Treatment

Opioid Treatment Services, Office-Based Opioid Treatment Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,

More information

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,

More information

Federal Response to Opioid Abuse Epidemic

Federal Response to Opioid Abuse Epidemic Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call

More information

7/13/2011. Welcome. How Do I Ask Questions? Agenda

7/13/2011. Welcome. How Do I Ask Questions? Agenda Welcome Thank you for joining us today. The webinar will begin in a few moments. If you haven t dialed into the audio (telephone) portion, please do so now: 1 (866) 516-5393 Access Code: 33403311 If you

More information

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011 Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids

More information

MEDICATION-ASSISTED DRUG TREATMENT AND CHILD WELL-BEING

MEDICATION-ASSISTED DRUG TREATMENT AND CHILD WELL-BEING MEDICATION-ASSISTED DRUG TREATMENT AND CHILD WELL-BEING Lena Lundgren, Ph.D.¹ Nancy K. Young, P.h.D.² Therese Fitzgerald, M.S.W.¹ Cat Oettinger, B.A. ¹ ¹ Center on Work and Family, Boston University ²

More information

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA

More information

Magee-Womens Hospital

Magee-Womens Hospital Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie

More information

Medications for Alcohol and Drug Dependence Treatment

Medications for Alcohol and Drug Dependence Treatment Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram

More information

What is Methadone? Opioid Treatment Programs Today. Is Methadone Safe? Pain Clinics. Wisconsin OTPs. Methadone Maintenance Treatment 5/6/2013

What is Methadone? Opioid Treatment Programs Today. Is Methadone Safe? Pain Clinics. Wisconsin OTPs. Methadone Maintenance Treatment 5/6/2013 Methadone Maintenance Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority April 22, 2013 What is Methadone? Schedule II pharmaceutical opioid similar to Oxycodone or morphine. Binds to the

More information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and

More information

The Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence

The Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence M00K02 Alcohol and Drug Abuse Administration Department of Health and Mental Hygiene The Use of Non-Opioid Pharmacotherapies for the Treatment of Alcohol Dependence Introduction The 2011 Joint Chairmen

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

the facts about NALTREXONE

the facts about NALTREXONE the facts about NALTREXONE for Treatment of Opioid Addiction It s not like I woke up one day when I was young and told myself, I wanna be a drug addict. I wanna ruin my life and ruin the lives of those

More information

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment

More information

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)

More information

Management of Pregnancy. Opioid Addiction Treatment

Management of Pregnancy. Opioid Addiction Treatment Management of Pregnancy Opioid Addiction Treatment Perinatal Opioid Addiction Pharmacotherapy and co-ordination of care are essential elements in the comprehensive care of pregnant patients with opioid

More information

Use of Buprenorphine in the Treatment of Opioid Addiction

Use of Buprenorphine in the Treatment of Opioid Addiction Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary Which of the following is an

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

Program Assistance Letter

Program Assistance Letter Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care

More information

Prescriber Behavior, Pain Treatment and Addiction Treatment

Prescriber Behavior, Pain Treatment and Addiction Treatment Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy

More information

5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome

5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome 5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is

More information

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,

More information

Update and Review of Medication Assisted Treatments

Update and Review of Medication Assisted Treatments Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

Naltrexone and Alcoholism Treatment Test

Naltrexone and Alcoholism Treatment Test Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score

More information

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment: Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society

More information

Opiate Abuse and Mental Illness

Opiate Abuse and Mental Illness visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?

More information

Advances in Addiction Science and Treatment. Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014

Advances in Addiction Science and Treatment. Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014 Advances in Addiction Science and Treatment Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014 Treatment Research Research Institute, Institute, 20132012 Presentation 1. What is driving

More information

Substance Abuse lifestyle Concern for mother - fetus - and - neonate

Substance Abuse lifestyle Concern for mother - fetus - and - neonate OBJECTIVES Learn about types of opioids and associated withdrawal symptoms Learn what medications are available to treat opioid addiction Understand the pros and cons associated with each medication Understand

More information

Southlake Psychiatry. Suboxone Contract

Southlake Psychiatry. Suboxone Contract Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to

More information

Treatment of opioid use disorders

Treatment of opioid use disorders Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

Increasing Issues of Polypharmacy and Off-Label Drug Use in Psychiatric Care

Increasing Issues of Polypharmacy and Off-Label Drug Use in Psychiatric Care Increasing Issues of Polypharmacy and Off-Label Drug Use in Psychiatric Care Stefan P. Kruszewski, MD Board Certified in Adult, Geriatric, Adolescent and Addiction Psychiatry, and Addiction Medicine Speaker

More information

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids

More information

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Heroin Overdose Trends and Treatment Options Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Type date here www.gatewayrehab.org Drug Overdose Deaths Increasing in Allegheny County Roberta Lojak holds

More information

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,

More information

Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?

Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier? Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier? Good News: Medical treatments called opioid (oh-pee-oyd) maintenance can help you! Injecting heroin puts you

More information

Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management

Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management June 10 and 11, 2011 Executive Summary Introduction Opioid

More information

Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism

Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University

More information

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain? Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears

More information

Rationale for and approach to treating Opiate Use Disorders

Rationale for and approach to treating Opiate Use Disorders Rationale for and approach to treating Opiate Use Disorders Gavin Bart, MD PhD FACP DFASAM Director, Division of Addiction Medicine Department of Medicine Hennepin County Medical Center Associate Professor

More information

Medication treatments for opioid use disorders

Medication treatments for opioid use disorders Medication treatments for opioid use disorders Summary for counties JUDITH MARTIN, Medical Director of Substance Use Services, San Francisco Department of Public Health Brief history of Methadone and Buprenorphine

More information

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),

More information

Medication for the Treatment of Alcohol Use Disorder. Pocket Guide

Medication for the Treatment of Alcohol Use Disorder. Pocket Guide Medication for the Treatment of Alcohol Use Disorder Pocket Guide Medications are underused in the treatment of alcohol use disorder. According to the National Survey on Drug Use and Health, of the estimated

More information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry

More information

Teenage Prescription Drug Abuse. Dr. Michael Fiori

Teenage Prescription Drug Abuse. Dr. Michael Fiori Teenage Prescription Drug Abuse Dr. Michael Fiori Conflict of Interest Disclosure Dr. Fiori has no relevant disclosures NIDA Superb resource for professionals, parents and teenagers Reporting and funding

More information

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15 ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB

More information

In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.

In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol. Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.

More information

A G U I D E F O R U S E R S N a l t r e x o n e U

A G U I D E F O R U S E R S N a l t r e x o n e U A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person

More information

MEDICAL POLICY Treatment of Opioid Dependence

MEDICAL POLICY Treatment of Opioid Dependence POLICY........ PG-0313 EFFECTIVE......11/11/14 LAST REVIEW... 07/14/15 MEDICAL POLICY Treatment of Opioid Dependence GUIDELINES This policy does not certify benefits or authorization of benefits, which

More information

Addiction Messenger Part 1: Medication-Assisted Treatment - Setting the Context

Addiction Messenger Part 1: Medication-Assisted Treatment - Setting the Context Addiction Messenger Part 1: - Setting the Context "When you love someone who suffers from the disease of addiction you await the phone call. There will be a phone call. T he sincere hope is that the call

More information

TREATMENT MODALITIES. May, 2013

TREATMENT MODALITIES. May, 2013 TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.

More information

PATHWAYS TO RECOVERY

PATHWAYS TO RECOVERY PATHWAYS TO RECOVERY PATHWAYS TO RECOVERY When Faces & Voices of Recovery was launched in 2001, our founding goal was to celebrate and honor recovery in all of its diversity. We believe that everyone has

More information

Opioid Use in Pregnancy: A Community s Approach, The Children and Recovering Mothers (CHARM) Collaborative

Opioid Use in Pregnancy: A Community s Approach, The Children and Recovering Mothers (CHARM) Collaborative Opioid Use in Pregnancy: A Community s Approach, The Children and Recovering Mothers (CHARM) Collaborative Nancy K. Young, PhD Sally Borden, MEd Karen Shea, MSW Agenda Overview of the Issue Medication

More information